Patent application rule struck down by appeals court
The Federal Circuit appeals court found that the Patent and Trademark Office's rule limiting the number of continuation applications a patent applicant may file conflicts with current law and is thus invalid. But it found that three other PTO rules limiting requests for continued examination and requiring an examination support document for certain filings are within the scope of PTO's rulemaking authority. Inventor Triantafyllos Tafas and GlaxoSmithKline challenged the rules in separate lawsuits, and they had won on all four rules in the district court (1"The Pink Sheet" DAILY, April 1, 2008). The district court must now reconsider the other rules in more detail
You may also be interested in...
Patent office lacks legal authority to make substantive changes to the law, district court says.
Valneva is scaling up manufacture of its coronavirus vaccine alongside the clinical development program, with a view to meeting its commitment to provide millions of doses for use in the UK and the EU.
The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.